Does regional treatment improve the survival in patients with operable breast cancer?

Breast Cancer Research and Treatment

Volumn 76, Issue 3, 2002, Pages 269-282

  Noguchi, Masakuni ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Axillary lymph node dissection; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; ANTINEOPLASTIC AGENT;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LYMPH NODE DISSECTION; MASTECTOMY; MEDLINE; PRIORITY JOURNAL; REGIONAL PERFUSION; REVIEW; SYSTEMIC THERAPY; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AXILLA; BREAST; BREAST TUMOR; CLINICAL PROTOCOL; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MORTALITY; OUTCOME ASSESSMENT; PATHOLOGY; PROSPECTIVE STUDY; STANDARD; SURVIVAL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC PROTOCOLS; AXILLA; BREAST; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; NEOPLASM INVASIVENESS; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036889953     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020803904035     Document Type: Review

References (78)

1. Noguchi M, Miwa K, Michigishi T, Yokoyama K, Nishijima H, Takanaka T, Kawashima H, Nakamura S, Kanno H, Nonomura A: The role of axillary lymph node dissection in breast cancer management. Breast Cancer 4: 143-153, 1997
2. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham L, Deutsch M, Montague E, Margolese R, Foster R: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674-681, 1985
3. Lythgoe JP, Leck I, Swindell R: Manchester regional breast study: Preliminary results. Lancet I: 744-747, 1978
4. Lythgoe JP, Palmer MK: Manchester regional breast study; 5 and 10 year results. Br J Surg 69: 693-696, 1982
5. Cancer Research Campaign Working Party: Cancer research campaign (King's/Cambridge) trial for early breast cancer: a detailed update at the tenth year. Lancet II (8185): 55-60, 1980
6. Fisher B: Laboratory and clinical research in breast cancer - A personal adventure: The David A. Karnofsky Memorial Lecture. Cancer Res 40: 3863-3874, 1980
7. Hellman S, Harris JR: Natural history of breast cancer. In: Harris JR (ed.) Diseases of the Breast. 2nd edn, Lippincott Williams & Wilkins, Philadelphia, 2000, pp 407-423
8. Hellman S, Harris JR: The appropriate breast carcinoma paradigm. Cancer Res 47: 339-342, 1987
9. Hellman S: Stopping metastases at their source. N Engl J Med 337: 996-997, 1997
10. Noguchi M, Taniya T: Biology and surgical management of breast cancer. Breast Cancer 8: 16-22, 2001
11. Sosa JA, Diener-West M, Gusev Y, Choti MA, Lange JR, Dooley WC, Zeiger MA: Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol 5: 140-149, 1998
12. Orr RK: The impact of prophylactic axillary node dissection on breast cancer survival: A Bayesian meta-analysis. Ann Surg Oncol 6: 109-116, 1999
13. Harris JR, Osteen RT: Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5: 17-21, 1995
14. Gardner B, Feldman J: Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg 218: 270-278, 1993
15. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CML, Paradis M, Coldman AJ, Olivotto IA: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337: 956-962, 1997
16. Ragaz J, Jackson SM, Le N, Manji M, Wilson K, Olivotto I, Coldman A, Spinelli J: Postmastectomy radiation outcome in node positive breast cancer patients among N1-3 versus N4+ subsets: Impact of extracapsular spread. Update of the British Columbia randomized trial. Proc Am Soc Clin Oncol 18: 73, 1999
17. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen M-B, Zedeler K: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337: 949-955, 1997
18. Overgaard M, Jensen M-B, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353: 1641-1648, 1999
19. Caceres E: An evaluation of radical mastectomy and extended radical mastectomy for cancer of the breast. Surg Gynecol Obstet 123: 337-341, 1967
20. Urban JA, Castro EB: Selecting variations in extent of surgical procedure for breast cancer. Cancer 28: 1615-1623, 1971
21. Veronesi U, Cascinelli N, Greco M, Bufalino R, Morabito A, Galluzzo D, Conti R, Lellis RD, Donne VD, Piotti P, Sacchini V, Clemente C, Salvadori B: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202: 702-707, 1985
22. Valagussa P, Bonnadona P, Veronesi U: Patterns of relapse and survival following radical mastectomy: Analysis of 716 consecutive patients. Cancer 41: 1170-1178, 1978
23. Noguchi M, Taniya T, Koyasaki N, Miyazaki I: A multivariate analysis of en bloc extended radical mastectomy versus conventional radical mastectomy in operable breast cancer. Int Surg 77: 48-54, 1992
24. Veronesi U, Valagussa P: Inefficacy of internal mammary node dissection in breast cancer surgery. Cancer 47: 170-175, 1981
25. Noguchi M, Tsugawa K, Taniya T, Miwa K: The role of internal mammary lymph node metastases in the management of breast cancer. Breast Cancer 5: 117-125, 1998
26. Noguchi M, Koyasaki N, Ohta N, Kitagawa H, Earashi M, Thomas M, Miyazaki I, Mizukami Y: Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer. Arch Surg 128: 242-246, 1993
27. Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R: The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-Year results of a randomized trial. Eur J Cancer 35: 1320-1325, 1999
28. Adair F, Berg J, Joubert L, Robbins GF: Long-term follow-up of breast cancer patients: The 30-year report. Cancer 33: 1145-1150, 1974
29. Joensuu H, Pylkkanen L, Toikkanen S: Long-term survival in node-positive breast cancer treated by locoregional therapy alone. Br J Cancer 78: 795-799, 1998
30. Rutqvist LE, Wallgren A: Long-term survival of 458 young breast cancer patients. Cancer 55: 658-665, 1985
31. Hibberd AD, Horwood LJ, Wells JE: Long term prognosis of women with breast cancer in New Zealand: Study of survival to 30 years. Br Med J 286: 1777-1779, 1983
32. Sutherland CM, Matter FJ: Charity hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional disease. Ann Surg 207: 569-579, 1988
33. Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S: A long-term follow-up study of survival in Stage I (T1N0M0) and Stage II (T1N1M0) breast carcinoma. J Clin Oncol 7: 355-366, 1989
34. Brinkley D, Haybittle JL: The curability of breast cancer. Lancet 2: 95-97, 1975
35. Fisher B, Fisher ER: Experimental evidence in support of the dormant tumor cells. Science 130: 918-919, 1959
36. Dent DM, Gudgeon CA, Murray EM: Mastectomy with axillary clearance versus mastectomy without it. S Afr Meal J 86: 670-671, 1996
37. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS: The Christie Hospital breast conservation trial: An update at 8 years from inception. Clin Oncol 5: 278-283, 1993
38. Bembenek A, Schlag PM: Lymph node dissection in breast cancer. Langenbeck's Arch Surg 385: 236-245, 2000
39. Langlands AO, Prescott RJ, Hamilton T: A clinical trial in the management of operable cancer of the breast. Br J Surg 67: 170-174, 1980
40. Hayward JL: The Guy's Hospital trials on breast conservation. In: Harris JR, Hellman S, Silen W (eds) Conservative Management of Breast Cancer, J.B. Lippincott, Philadelphia, 1983, pp 77-90
41. Hayward J, Caleffi M: The significance of local control in the primary treatment of breast cancer. Arch Surg 122: 1244-1247, 1987
42. Hayward JL: The Guy's trial of treatment of "early" breast cancer. World J Surg 1: 314-316, 1977
43. Chetty U, Jack W, Prescott RJ, Tyler C, Rodger A: Management of the axilla in operable breast cancer treated by breast conservation: A randomized clinical trial. Br J Surg 87: 163-169, 2000
44. Cabanes PA, Salmon RJ, Vilcoq JR, Durand JC, Fourquet A, Gautier C, Asselain B: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339: 1245-1248, 1992
45. Urban JA: Breast cancer 1985. Cancer 57: 636-643, 1986
46. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 333: 1444-1455, 1995
47. Early Breast Cancer Trialists' Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 355: 1757-1770, 2000
48. Rutqvist LE: Radiation therapies for breast cancer: current knowledge on advantages and disadvantages. In: Senn HJ, Belber RD, Goldhirsch A, Thurlimann B (eds) Recent Results in Cancer Research. Vol 127: Adjuvant Therapy of Breast Cancer IV, Springer-Verlag, Berlin-Heidelberg, 1993, pp 119-127
49. Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2: 335-340, 1993
50. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391-401, 1994
51. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patients with breast cancer. J Am Med Assoc 276: 1818-1822, 1996
52. Dixon, M: Sentinel node biopsy in breast cancer. A promising technique, but it should not be introduced without proper trials. Br Med J 317: 295-296, 1998
53. McNeil C: Four large studies aim to resolve sentinel node debate. J Natl Cancer Inst 90: 729, 1998
54. Lacour J, Bucalossi P, Caceres E, Jacobelli G, Koszarowski T, Le M, Rumeau-Rouquette C, Veronesi U: Radical mastectomy versus radical mastectomy plus internal mammary dissection: Five-year results of an international cooperative study. Cancer 37: 206-214, 1976
55. Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C: Radical mastectomy versus radical mastectomy plus internal mammary dissection: Ten-year results of an international cooperative trial in breast cancer. Cancer 51: 1941-1943, 1983
56. Morimoto T, Monden Y, Takashima S, Itoh S, Kimura T, Yamamoto H, Kitamura M, Inui K, Tanaka N, Nagano T, Fujishima N, Yanada J, Tsuruno M, Komaki K: Five-year results of a randomized clinical trial comparing modified radical mastectomy and extended radical mastectomy for stage II breast cancer. Surg Today 24: 210-214, 1994
57. Lacour J, Le GM, Hill C, Kramar A, Contesso G, Sarrazin D: Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol 13: 309-314, 1987
58. Meier P, Ferguson DJ, Karrison T: A controlled trial of extended radical mastectomy. Cancer 56: 880-891, 1985
59. Meier P, Ferguson DJ, Karrison T: A controlled trial of extended radical mastectomy: Ten-year results. Cancer 63: 188-195, 1989
60. Noguchi M, Thomas M, Kitagawa H, Kinoshita K, Ohta N, Nagamori M, Miyazaki I: Further analysis of predictive value of Helix pomatia lectin binding to primary breast cancer for axillary and internal mammary lymph node metastases. Br J Cancer 67: 1368-137, 1993
61. Veronesi U, Cascinelli N, Bufalino R, Morabito A, Greco M, Galluzzo D, Donne VD, Lellis RD, Piotti P, Sacchini V, Conti R, Clemente C: Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 198: 681-684, 1983
62. Cody III HS, Urban JA: Internal mammary node status: A major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 2: 32-37, 1995
63. Paterson R, Russell MH: Clinical trials in malignant disease Part III. Breast cancer: Evaluation of postoperative radiotherapy. J Faculty Radiol 10: 175-180, 1959
64. Palmer MK, Ribeiro GG: Thirty-four year follow-up of patients with breast cancer in clinical trial of postoperative radiotherapy. Br Med J 291: 1088-1091, 1985
65. Fisher B, Slack NH, Cavanaugh PJ, Gardner B, Ravdin RG: Postoperative radiotherapy in the treatment of breast cancer: Results of the NSABP clinical trial. Ann Surg 172: 711-732, 1970
66. Host H, Brennhovd IO, Loeb M: Postoperative radiotherapy in breast cancer: Long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12: 727-732, 1986
67. Wallgren A, Arner O, Bergstrom J, Blomstedt B, Granberg P-O, Raf L, Silfversward C, Einhorn J: Radiation therapy in operable breast cancer: Results from the Stockholm trial on adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 12: 533-537, 1986
68. Noguchi M, Miyazaki I: The surgical management of breast cancer. Int Surg 75: 8-14, 1990
69. Khayat D: Commentary on "A survival benefit from locoregional therapy: Implication for Halsted's hypothesis (Editorial)". Breast Cancer 9: 6-7, 2002
70. Noguchi M: A survival benefit from locoregional therapy: implication for Halsted's hypothesis (Editorial). Breast Cancer 9: 3-5, 2002
71. Noguchi M, Kinne DW, Miyazaki I: Controversies in the surgical management of operable breast cancer. Breast Cancer 1: 79-88, 1994
72. Cuzick J, Stewart H, Peto R, Baum M, Fisher B, Host H, Lythgoe JP, Ribeiro G, Scheurlen H, Wallgren A: Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71: 15-29, 1987
73. Cuzick J, Stewart H, Peto R, Baum M, Fisher B, Host H, Lythgoe JP, Ribeiro G, Scheurlein H, Wallgren A: Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat Rep 71: 7-14, 1987
74. Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML: Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18: 1220-1229, 2000
75. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge Jr GW, Whelan TJ, Pfister DG: Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19: 1539-1569, 2001
76. Morrow M: A survival benefit from axillary dissection: Was Halsted correct? Ann Surg Oncol 16: 17-18, 1999
77. Halsted W: The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Bull 4: 297, 1895
78. Noguchi M: Sentinel lymph node biopsy and breast cancer. Br J Surg 89: 21-34, 2002